Mechanism of the interferon alpha response against hepatitis C virus replicons

Virology

Volumn 325, Issue 1, 2004, Pages 71-81

  Guo, Ju Tao ^a   Sohn, Ji A ^a   Zhu, Qing ^a   Seeger, Christoph ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Hepatitis C virus; IFN ; RNA amplification

Indexed keywords

ANTIVIRUS AGENT; CYTOKINE; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ARTICLE; CELL LINE; CONTROLLED STUDY; HEPATITIS C VIRUS; NONHUMAN; PRIORITY JOURNAL; REPLICON; RNA SYNTHESIS; VIRUS REPLICATION;

HEPACIVIRUS; HUMANS; INTERFERON-ALPHA; PROTEIN BIOSYNTHESIS; REPLICON; RNA REPLICASE; RNA, VIRAL; VIRAL PROTEINS;

HEPATITIS C VIRUS;

EID: 3042660285     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.04.031     Document Type: Article

References (33)

1. Alter H.J., Seeff L.B. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin. Liver Dis. 20(1):2000;17-35
2. Bigger C.B., Brasky K.M., Lanford R.E. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J. Virol. 75(15):2001;7059-7066
3. Blight K.J., Kolykhalov A.A., Rice C.M. Efficient initiation of HCV RNA replication in cell culture [In Process Citation]. Science. 290:2000;1972-1975
4. Carroll S.S., Tomassini J.E., Bosserman M., Getty K., Stahlhut M.W., Eldrup A.B., Bhat B., Hall D., Simcoe A.L., LaFemina R., Rutkowski C.A., Wolanski B., Yang Z., Migliaccio G., De Francesco R., Kuo L.C., MacCoss M., Olsen D.B. Inhibition of hepatitis C virus RNA replication by 2′-modified nucleoside analogs. J. Biol. Chem. 278(14):2003;11979-11984
5. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244(4902):1989;359-362
6. Chu P.W., Westaway E.G. Replication strategy of Kunjin virus: evidence for recycling role of replicative form RNA as template in semiconservative and asymmetric replication. Virology. 140(1):1985;68-79
7. Der S.D., Zhou A., Williams B.R., Silverman R.H. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. U.S.A. 95(26):1998;15623-15628
8. Di Bisceglie A.M., Hoofnagle J.H. Optimal therapy of hepatitis C. Hepatology. 36(5 Suppl. 1):2002;S121-S127
9. Egger D., Wolk B., Gosert R., Bianchi L., Blum H.E., Moradpour D., Bienz K. Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J. Virol. 76(12):2002;5974-5984
10. Frese M., Pietschmann T., Moradpour D., Haller O., Bartenschlager R. Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. J. Gen. Virol. 82(Pt. 4):2001;723-733
11. Guo J.T., Pugh J.C. Topology of the large envelope protein of duck hepatitis B virus suggests a mechanism for membrane translocation during particle morphogenesis. J. Virol. 71(2):1997;1107-1114
12. Guo J.T., Bichko V.V., Seeger C. Effect of alpha interferon on the hepatitis C virus replicon. J. Virol. 75(18):2001;8516-8523
13. Guo J.-T., Zhu Q., Seeger C. Cytopathic and non-cytopathic interferon responses in cells expressing hepatitis C virus subgenomic replicons. J. Virol. 77(20):2003;10769-10779
14. Isaacs A., Lindenmann J. Virus interference. I. The interferon. Proc. R. Soc., B. 147:1957;258-267
15. Kato J., Kato N., Moriyama M., Goto T., Taniguchi H., Shiratori Y., Omata M. Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway. J. Infect. Dis. 186(2):2002;155-163
16. Khromykh A.A., Meka H., Guyatt K.J., Westaway E.G. Essential role of cyclization sequences in flavivirus RNA replication. J. Virol. 75(14):2001;6719-6728
17. Kinzie J.L., Naylor P.H., Nathani M.G., Peleman R.R., Ehrinpreis M.N., Lybik M., Turner J.R., Janisse J.J., Massanari M., Mutchnick M.G. African Americans with genotype 1 treated with interferon for chronic hepatitis C have a lower end of treatment response than Caucasians. J. Viral Hepatitis. 8(4):2001;264-269
18. Koev G., Duncan R.F., Lai M.M. Hepatitis C virus IRES-dependent translation is insensitive to an eIF2alpha-independent mechanism of inhibition by interferon in hepatocyte cell lines. Virology. 297(2):2002;195-202
19. Lohmann V., Korner F., Koch J., Herian U., Theilmann L., Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science. 285(5424):1999;110-113
20. McHutchison J.G., Gordon S.C., Schiff E.R., Shiffman M.L., Lee W.M., Rustgi V.K., Goodman Z.D., Ling M.H., Cort S., Albrecht J.K. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N. Engl. J. Med. 339(21):1998;1485-1492
21. Neumann A.U., Lam N.P., Dahari H., Gretch D.R., Wiley T.E., Layden T.J., Perelson A.S. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science. 282(5386):1998;103-107
22. Pietschmann T., Lohmann V., Rutter G., Kurpanek K., Bartenschlager R. Characterization of cell lines carrying self-replicating hepatitis C virus RNAs. J. Virol. 75(3):2001;1252-1264
23. Pugh J.C., Sninsky J.J., Summers J.W., Schaeffer E. Characterization of a pre-S polypeptide on the surfaces of infectious avian hepadnavirus particles. J. Virol. 61(5):1987;1384-1390
24. Reed K.E., Rice C.M. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr. Top. Microbiol. Immunol. 242:2000;55-84
25. Sen G.C. Viruses and interferons. Annu. Rev. Microbiol. 55:2001;255-281
26. Shimazaki T., Honda M., Kaneko S., Kobayashi K. Inhibition of internal ribosomal entry site-directed translation of HCV by recombinant IFN-alpha correlates with a reduced La protein. Hepatology. 35(1):2002;199-208
27. Shimizu Y.K., Iwamoto A., Hijikata M., Purcell R.H., Yoshikura H. Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proc. Natl. Acad. Sci. U.S.A. 89(12):1992;5477-5481
28. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 67:1998;227-264
29. Sung V.M., Shimodaira S., Doughty A.L., Picchio G.R., Can H., Yen T.S., Lindsay K.L., Levine A.M., Lai M.M. Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J. Virol. 77(3):2003;2134-2146
30. Wang C., Pflugheber J., Sumpter R. Jr., Sodora D.L., Hui D., Sen G.C., Gale M. Jr. Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication. J. Virol. 77(7):2003;3898-3912
31. Westaway E.G., Mackenzie J.M., Kenney M.T., Jones M.K., Khromykh A.A. Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3 with double-stranded RNA, and of NS2B with NS3, in virus-induced membrane structures. J. Virol. 71(9):1997;6650-6661
32. Westaway E.G., Khromykh A.A., Mackenzie J.M. Nascent flavivirus RNA colocalized in situ with double-stranded RNA in stable replication complexes. Virology. 258(1):1999;108-117
33. Zhu Q., Guo J.T., Seeger C. Replication of hepatitis C virus subgenomes in nonhepatic epithelial and mouse hepatoma cells. J. Virol. 17:2003;9204-9210